Search - tctmd.com

Displaying 1 - 20 of 88

Sort: Relevancy | Date

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

Yael L. Maxwell

February 27, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Todd Neale

January 16, 2024

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men

Yael L. Maxwell

February 21, 2023

News Daily News

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Michael O'Riordan

January 12, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

Advertisement

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Most Patient-Reported Outcome Measures in CVD Fall Short

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content